Novonordisk.com - Levemir for Diabetes and Hypoglycaemia

Novo Nordisk country sites USA Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Croatia Czech Republic Denmark Egypt Estonia Finland France Germany Greece Hungary India Iraq Ireland Israel Italy Japan Korea (Republic) Latvia Lebanon Lithuania Mexico Netherlands New Zealand Norway Pakistan Poland Portugal Romania Russian Federation Serbia Slovak Republic Slovenia South Africa Spain Sweden Switzerland Syria Taiwan Thailand Turkey Ukraine United Kingdom Other Novo Nordisk sites Changing diabetes DAWN study Hagedorn Research Institute Diabetes4Patients Diabetes Barometer Changing diabetes bus Media prize World diabetes day School challenge Improve Control HRT for HCPs HRT for women HRT congresses & symposia

Victoza®

• Underlying problems in type 2 diabetes
• Mode of action
• Efficacy and safety
• Dosing and administration
• Prescribing information
• Treatment guidelines

•  

• Rate this page
• Send to a friend
• Print

Safety

In a clinical study, once-daily Levemir® in combination with OADs showed lower risk of hypoglycaemia (both nocturnal and all hypos) when compared to NPH insulin4